Blood levels of glial fibrillary acidic protein for predicting clinical progression to Alzheimer’s disease in adults without dementia: a systematic review and meta-analysis protocol

Blood levels of glial fibrillary acidic protein for predicting clinical progression to Alzheimer’s disease in adults without dementia: a systematic review and meta-analysis protocol

Abstract Background There is urgent clinical need to identify reliable prognostic biomarkers that predict the progression of dementia symptoms in individuals with early-phase Alzheimer’s disease (AD) especially given the research on and predicted applications of amyloid-beta (Aβ)-directed immunother...

Full description

Bibliographic Details
Main Authors: Takashi Nihashi, Keita Sakurai, Takashi Kato, Yasuyuki Kimura, Kengo Ito, Akinori Nakamura, Teruhiko Terasawa
Format: Article
Language:English
Published: BMC 2024-03-01
Series:Diagnostic and Prognostic Research
Subjects:
Alzheimer’s disease
Biomarker
Dementia
Meta-analysis
Mild cognitive impairment
Prediction
Online Access:https://doi.org/10.1186/s41512-024-00167-3

Internet

https://doi.org/10.1186/s41512-024-00167-3

Similar Items